SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant momentum as investors pivot toward its QNX software as a foundational infrastructure play for physical AI and robotics. The community is actively celebrating this price action as a long-awaited turnaround, with many shareholders positioning for potential sustained growth as the company shifts from a legacy narrative to a high-margin software focus.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently caught in a period of intense volatility as traders debate the implications of shifting geopolitical tensions and speculative reports regarding a potential US-Iran peace agreement. While the community remains deeply divided between long-term holders advocating for accumulation and skeptics questioning its long-term viability against emerging threats like quantum computing, price action remains stalled near key resistance levels as market participants look for a clear catalyst to break the current consolidation.

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is trending after reporting positive preclinical data showing synergy between its AKTX-101 ADC and KRAS inhibitors for treating pancreatic cancer. The stock has seen significant volatility and high retail participation as the community debates whether the technical setup and potential for a squeeze signal a sustainable reversal or another speculative biotech trap.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space Inc is drawing significant investor interest following a $17.5 million private placement meant to scale its STARLAUNCH platform, though the community remains polarized as they debate the firm's path to commercial profitability. Discussions are heavily focused on the stock's potential for a short squeeze ahead of the highly anticipated SpaceX IPO, while skeptics continue to flag concerns regarding the company's lack of current revenue and pending leadership-related legal challenges.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending due to a surge in its AI infrastructure business and strong institutional participation, with the stock recently hitting new highs amid reports of increased server backlog and enterprise AI demand. The community is actively debating its valuation compared to peers like Super Micro, while monitoring institutional call flow and analyst price target adjustments as the company solidifies its position in the broader AI supply chain.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is facing intense downward pressure despite posting strong quarterly earnings, fueling community frustration over suspected market manipulation and institutional shorting. Investors are actively debating the disconnect between the company's improved fundamentals and its stagnant share price, leading many to push for regulatory investigations and organized petitions.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing a surge in momentum and high-volume trading following the disclosure of a significant new stake by Leopold Aschenbrenner's Situational Awareness fund, fueling intense speculation around its role in the AI infrastructure and energy sector. Investors are actively debating the potential for a short squeeze as the stock attracts massive call option volume and moves toward key psychological resistance levels, with many viewing recent short-seller reports as opportunities for accumulation.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum faces significant downward pressure as institutional outflows and lingering macro concerns weigh on investor sentiment. The community remains deeply divided, with vocal bears highlighting the lack of price momentum while proponents focus on long-term utility, RWA tokenization potential, and upcoming regulatory catalysts.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense investor focus as its massive rally in the photonics and semiconductor material sector drives debate over whether its valuation is supported by genuine indium phosphide supply constraints or inflated by speculative hype. While bulls highlight critical market bottlenecks and AI-driven growth narratives, bears are actively pointing to significant insider selling, lack of profitability, and the pending shareholder vote to increase authorized shares as clear signs of a potential correction.

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Lantheus Holdings Inc

Lantheus Holdings is trending as investors digest its latest earnings and evaluate the company's long-term growth potential in the radiopharmaceutical sector. The community is actively discussing the stock's valuation, recent share repurchases, and strategic interest in emerging radiopharmaceutical players like Radiopharm Theranostics.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?

Key PointsDirector Lynne Ward sold 5,000 shares on May 7, 2026 for a transaction value of ~$313,000 at around $62.61 per share...

Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Merit Medical Systems (NASDAQ:MMSI) Reaches New 12-Month Low Following Analyst Downgrade

Merit Medical Systems (NASDAQ:MMSI) Reaches New 12-Month Low After Analyst Downgrade...

Merit Medical Systems (NASDAQ:MMSI) Given New $85.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group decreased their price target on shares of Merit Medical Systems from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Friday...

JPMorgan Chase & Co. Cuts Merit Medical Systems (NASDAQ:MMSI) Price Target to $77.00

JPMorgan Chase & Co. dropped their price target on Merit Medical Systems from $95.00 to $77.00 and set an "overweight" rating for the company in a research report on Friday...

Merit Medical Systems (NASDAQ:MMSI) Price Target Lowered to $74.00 at Wells Fargo & Company

Wells Fargo & Company lowered their target price on shares of Merit Medical Systems from $78.00 to $74.00 and set an "equal weight" rating on the stock in a report on Friday...

Merit Medical Systems (NASDAQ:MMSI) Stock Price Down 5.7% on Analyst Downgrade

Merit Medical Systems (NASDAQ:MMSI) Stock Price Down 5.7% Following Analyst Downgrade...

Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up

MMSI tops Q1 estimates with 9% EPS growth and 7% revenue rise, while lifting its 2026 sales outlook amid steady segment and geographic gains.

Needham & Company LLC Has Lowered Expectations for Merit Medical Systems (NASDAQ:MMSI) Stock Price

Needham & Company LLC reduced their price objective on Merit Medical Systems from $101.00 to $90.00 and set a "buy" rating on the stock in a report on Friday...

Merit Medical Systems Q1 Earnings Call Highlights

Merit Medical Systems (NASDAQ:MMSI) reported first-quarter 2026 results that exceeded the high end of the company's expectations, driven by steady U.S. demand, contributions from recent acquisitions, and record first-quarter profitability. Management also detailed a post-quarter oncology acquisition...

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

MMSI
Merit Medical Systems, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest MMSI News

MMSIMerit Medical Systems, Inc.